US Patent 10406366 Transvenous phrenic nerve stimulation system
Patent 10406366 was granted and assigned to Respicardia, Inc. on September, 2019 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10406366 Transvenous phrenic nerve stimulation system
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
